Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coagulopathy in Childhood Acute Lymphoblastic Leukaemia, Underlying Mechanisms and Ways to Optimise Treatment

NCT06242353 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT06242353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06242353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia, Underlying Mechanisms and Ways to Optimise Treatment
Lead sponsor
Karolinska University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2024
Completion date
November 30, 2028
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, bleeding, hemostatic disorder, thrombosis